Milan, Italy

Valentina Appierto



 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Valentina Appierto: Innovator in Cancer Research

Introduction

Valentina Appierto is a distinguished inventor based in Milan, Italy, known for her significant contributions to the field of cancer research. With her innovative approach and dedication to medical advancements, she has made noteworthy strides in therapeutic agent development.

Latest Patents

Valentina holds one patent focused on a promising compound, identified as 4-oxo-N-(4-hydroxyphenyl)retinamide derivatives, aimed at providing therapeutic solutions for cancer treatment. This invention represents a critical advancement in the fight against cancer, showcasing her commitment to improving patient outcomes through scientific innovation.

Career Highlights

Valentina works at the Fondazione IRCCS “Istituto Nazionale dei Tumori,” an institution recognized for its rigorous research in oncology. Her work there has aligned her with groundbreaking projects that contribute to cancer therapeutics and treatment methodologies. Her dedication and research acumen have placed her at the forefront of innovative cancer treatments.

Collaborations

During her career, Valentina has collaborated with esteemed colleagues such as Maria Grazia Daidone and Paola Tiberio. These partnerships have fostered a collaborative environment that enhances research initiatives and drives significant discoveries in the oncology field. Together, they work towards creating tangible solutions for complex medical challenges.

Conclusion

Valentina Appierto exemplifies the spirit of innovation within the field of cancer research. Her contributions through her patented compounds and collaborative efforts with other experts illustrate her essential role in developing new therapeutic approaches. As she continues her work at her institution, her passion for improving cancer treatment remains evident, inspiring future generations of researchers and inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…